Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40

Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40. Platelets are potential contributors to glomerular injury via the release of chemotactic and/or mitogenic mediators upon activation or through direct CD154/CD40-dependent interaction w...

Full description

Saved in:
Bibliographic Details
Published inKidney international Vol. 68; no. 5; pp. 2068 - 2078
Main Authors Delmas, Yahsou, Viallard, Jean-François, Solanilla, Anne, Villeneuve, Julien, Pasquet, Jean-Max, Belloc, Francis, Dubus, Isabelle, Dachanet-Merville, Julie, Merville, Pierre, Blanco, Patrick, Pellegrin, Jean-Luc, Nurden, Alan T., Combe, Christian, Ripoche, Jean
Format Journal Article
LanguageEnglish
Published New York, NY Elsevier Inc 01.11.2005
Nature Publishing
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40. Platelets are potential contributors to glomerular injury via the release of chemotactic and/or mitogenic mediators upon activation or through direct CD154/CD40-dependent interaction with cell components of the glomerulus. We examined whether platelets could activate mesangial cells and the potential role of the platelet-associated CD154. Thrombin-activated platelets from systemic lupus erythematosus (SLE) patients or from disease or healthy controls were grown with human mesangial cells in the presence or not of a neutralizing anti-CD154 antibody either in contact or in a noncontact setting, the platelets and mesangial cells being separated by a pore size semipermeable membrane. The induction of mesangial cell surface antigens was assayed by flow cytometry. The quantification of mesangial cell proliferation was performed by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay and the production of transforming growth factor-β1 (TGF-β1), platelet-derived growth factor (PDGF) and soluble CD40 were measured by enzyme-linked immunosorbent assay (ELISA). Activated platelets from patients with SLE could induce an up-regulation of the expression of CD40 on mesangial cells with a concomitant release of soluble CD40. This induction required a direct contact between platelets and mesangial cells and was dependent upon the platelet-associated CD154. Pathologic consequences of the up-regulation of CD40 were a CD40-dependent stimulation of the proliferation of mesangial cells and a CD40-dependent increased production of TGF-β1 by these cells. Platelets from patients with SLE can activate mesangial cells through CD40/CD154 interactions, leading to an induction of proliferation of the mesangial cells and an enhanced production of TGF-β1, a profibrotic cytokine.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0085-2538
1523-1755
DOI:10.1111/j.1523-1755.2005.00663.x